freeboard
Àü¿ì´ëÈ­¹æ ´ñ±Û´Þ±â
¿å¼³. Àü¿ìµéÀÇ ¸í¿¹¼Õ»ó±Û, ºñ³­.ƯÁ¤ Á¾±³³ª Á¤´ç¿¡ ´ëÇÑ ºñ³­À̳ª »ó¾÷¼º ±ÛÀº ¹«Á¶°Ç ½ÏÁ¦ ÇÕ´Ï´Ù.
¡Ø.ȸºñ ÀÔ±Ý ¿ìü±¹ÅëÀå °èÁÂ(700096-01-000631)=Çѱ¹ º£ÀÎÀü
¤ýÀÛ¼ºÀÚ ÃÖ»ó¿µ
¤ýÀÛ¼ºÀÏ 2010-07-06 (È­) 21:11
¤ýÁ¶È¸: 2303  
º£Æ®³² ÂüÀü °í¿±Á¦ ȯÀÚ¿¡¼­½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ýÀÌ ´õ ÈçÇÑ°¡?
´ëÇѳ»°úÇÐȸÁö : Á¦ 73 ±Ç Á¦ 3 È£ 2007
- 299 -
º£Æ®³² ÂüÀü °í¿±Á¦ ȯÀÚ¿¡¼­
½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ýÀÌ ´õ ÈçÇÑ°¡?
±¤ÁÖº¸Èƺ´¿ø ¼øȯ±â³»°ú, Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ2
°­¿øÀ¯․±èÇѱÕ․Á¤¸íÈ£2․Á¶»óö․Á¤¾È´ö
Á¶¿ëÂù․±â¿µÈ­․À̺À±Ô․Ȳ¼±È£․±è ¿ø․±è ¿Ï
=Abstract=
Is cardiovascular disease more common in
Vietnam veterans exposed to agent orange?
Won Yu Kang, M.D., Han Gyun Kim, M.D., Myung Ho Jeong, M.D.2, Sang Cheol Cho, M.D.,
An Doc Jung, M.D., Yong Chan Cho, M.D., Young Hwa Ki, M.D., Bong Gyu Lee, M.D.,
Sun Ho Hwang, M.D., Weon Kim, M.D., PhD. and Wan Kim, M.D.
Division of Cardiology, Department of Internal Medicine, Gwangju Veterans Hospital, Gwangju, Korea
The Heart Center of Chonnam National University Hospital2, Gwangju, Korea
Background : TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin), a material of agent orange, was reported as a deadly
poison in spite of its presence at extremely small doses. It has been reported that TCDD can cause various kinds of
cancers and harmful effects on humans. However, a correlation between exposure to TCDD and cardiovascular disease
is not yet known. Thus, we intended to examine the correlation between TCDD exposure and cardiovascular disease
through an analysis of coronary angiograms in veterans of the Vietnam War.
Methods : A consecutive 115 patients undergoing coronary angiograms between April 2004 and June 2005 at Gwangju
Veterans Hospital were analyzed. The patients were divided into two groups: 57 patients exposed to TCDD (Group I,
average age 59.2¡¾4.2 years) and 58 patients that were not exposed to TCDD (Group II, Average age 60.1¡¾5.6 years).
The clinical and coronary angiographic findings were evaluated.
Results : Baseline clinical characteristics, inflammatory markers and echocardiographic parameters were not different
between patients in the two groups. The incidence of diabetes (43.9% vs. 25.0%, p=0.035) and hyperlipidemia (47.4% vs.
27.6%, p=0.028) were higher in group I patients than group II patients. Significant coronary artery stenosis was more
common in group I (45 cases, 78.9%) thanin group II (33 cases, 56.9%) (p=0.011).
Conclusions : There was a higher incidence of diabetes, hyperlipidemia, and significant coronary artery stenosis in
patients that underwent a diagnostic coronary angiogram that were previously exposed to TCDD.(Korean J Med
73:299-306, 2007)
Key Words : Drugs, Coronary diseases, Angioplasty
∙Received : 2006. 7. 7
∙Accepted : 2006. 8. 28
∙Correspondence to : Han Gyun Kim, M.D., Division of cardiology, Department of Internal Medicine, Gwangju Veterans Hospital, 887-1
Sanwol-dong, Gwangsan-gu, Gwangju 506-705, Korea E-mail :
onebac@nate.com
*This research was performed under support of the cardiovascular research foundation(CVRF), and we showed the oral presentation in
the 56th annual scientific meeting of the Korean association of internal medicine held on October 27-28, 2005.

 
£­ The Korean Journal of Medicine : Vol. 73, No. 3, 2007 £­
- 300 -
¼­ ·Ð
°í¿±Á¦(Agent orange)´Â º£Æ®³² ÀüÀï ´ç½Ã ¹Ì±ºÀÌ Àû
±ºÀÇ Àº½Åó³ª ¾Æ±ºÀÇ ½Ã°èû¼Ò¸¦ À§ÇØ »ç¿ëÇÑ ¹°Áú·Î,
±× Áß dioxinÀ¸·Î Àß ¾Ë·ÁÁø TCDD (2,3,7,8-tetrachlorodibenzo-
p-dioxin)´Â ¹Ì·® Æ÷ÇԵǾî ÀÖÀ¸³ª, ¼Ò·®
À¸·Îµµ ÀÎü¿¡ ¸Íµ¶¼ºÀÌ ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù1, 2).
DioxinÀÌ ÀÏ´Ü Ã¼³»·Î µé¾î¿Ã °æ¿ì¿¡ ü¿Ü·Î ¹è¼³ÀÌ µÇ
Áö ¾Ê°í ü³»¿¡ ÃàÀûµÊÀ¸·Î½á, Àå±âÀûÀ¸·Î ÇÕº´ÁõÀ» ¹ß
»ý½ÃŲ´Ù3, 4).
ÇÏÁö¸¸ °í¿±Á¦¿Í ÀÌ·Î ÀÎÇÑ ÈÄÀ¯Áõ¿¡ ´ëÇÑ ¸íÈ®ÇÑ ÀÎ
°ú°ü°è°¡ ¹àÇôÁ® ÀÖ´Â °ÍÀÌ ¸¹Áö ¾ÊÀ¸¸ç, ƯÈ÷ °íÇ÷¾Ð,
°íÁöÇ÷Áõ, µ¿¸Æ°æÈ­Áõ, ±×¸®°í ÇãÇ÷¼º ½ÉÁúȯÀÇ ¹ß»ý°ú
°í¿±Á¦ÀÇ Àΰú°ü°è´Â ºÒºÐ¸íÇÑ »óÅÂÀÌ´Ù.
ÀúÀÚ µîÀº º£Æ®³² ÀüÀï¿¡ Æĺ´µÇ¾ú´ø ȯÀÚµéÀ» ´ë»ó
À¸·Î ÇÏ¿© °í¿±Á¦°¡ ½ÉÇ÷°üÁúȯÀÇ ¹ßº´¿¡ ¾î¶°ÇÑ ¿µÇâ
À» ¹ÌÄ¡´ÂÁö¿Í °í¿±Á¦¿¡ Æø·ÎµÇ¾ú´ø »ç¶÷µéÀÇ ½ÉÇ÷°ü
ÁúȯÀÇ Æ¯Â¡À» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý
1. ´ë»ó ȯÀÚ
2004³â 4¿ùºÎÅÍ 2005³â 6¿ù±îÁö ±¤ÁÖº¸Èƺ´¿ø¿¡¼­ Çù
½ÉÁõÀ¸·Î °ü»óµ¿¸Æ Á¶¿µ¼úÀ» ½ÃÇàÇÑ È¯ÀÚµéÀ» ´ë»óÀ¸·Î
ÇÏ¿´´Ù. ³ªÀÌ´Â º£Æ®³² ÀüÀï´ç½Ã Çѱ¹±º Æĺ´ ±â°£À» °í
·ÁÇÏ¿© 50 ³»Áö 70¼¼ÀÇ ³²ÀÚ È¯ÀÚ·Î Á¦ÇÑÇÏ¿´´Ù. °í¿±Á¦
¿¡ ³ëÃâµÈ ȯÀÚ¸¦ I±º(57¸í), ³ëÃâµÇÁö ¾ÊÀº ȯÀÚ, Áï º£
Æ®³² ÀüÀï¿¡ Æĺ´µÇÁö ¾Ê¾ÒÀ¸¸ç ±âŸ °í¿±Á¦ ³ëÃâµÉ À§
Ç輺ÀÌ ÀÖ´Â Á÷¾÷·Â µîÀÌ ¾ø´Â ȯÀÚ¸¦ II±º(58¸í)À¸·Î ºÐ
·ùÇÏ¿© ºñ±³ ºÐ¼®ÇÏ¿´´Ù.
2. ¹æ¹ý
´ë»ó ȯÀÚ´Â ³»¿ø ½Ã ÀÛ¼ºµÈ Àǹ«±â·ÏÁö ¹× °ü»óµ¿¸Æ
Á¶¿µ¼ú ¼Ò°ßÀ» Åä´ë·Î ÇÏ¿© ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. ȯ
ÀÚÀÇ ³ªÀÌ, üÁú·®Áö¼ö(body mass index: BMI), °ü»óµ¿
¸Æ ÁúȯÀÇ À§ÇèÀÎÀÚ(°íÇ÷¾Ð, ´ç´¢º´, °íÁöÇ÷Áõ, Èí¿¬), ¹ß
¸ñ»ó¿ÏÁö¼ö/¸ÆÆÄÀüÆļӵµ(Ankle brachial index/Pulse
wave velocity: ABI/PWV), Framingham risk score5),
°Ë»ç½Ç ¼Ò°ß, ½ÉÃÊÀ½Æĵµ¿¡¼­ ÁÂ½É½Ç ±¸Ç÷À² µîÀ» Á¶»ç
ÇÏ¿´´Ù. °ü»óµ¿¸Æ Á¶¿µ¼ú¿¡¼­ ¼¼ Ç÷°ü Áß ÇÑ Ç÷°ü¿¡¼­¶ó
µµ 50% ÀÌ»óÀÇ ÇùÂøÀ» º¸ÀÌ´Â °æ¿ì º´º¯ÀÌ ÀÖ´Â °ÍÀ¸·Î
Á¤ÀÇÇÏ¿´´Ù.
°ü»óµ¿¸Æ Á¶¿µ¼úÀº GE INOVA 2000¢ç·Î ½ÃÇàÇÏ¿´À¸
¸ç, Á¤·®Àû °ü»óµ¿¸Æ ºÐ¼®Àº Cardiology AI 1000¢çÀÇ ÇÁ
·Î±×·¥À» ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÏ¿´´Ù. ¼º°øÀûÀÎ °æÇÇÀû °ü»óµ¿
¸Æ ÁßÀç¼ú(percutaneous coronary intervention: PCI)ÀÇ
Á¤ÀÇ´Â »ç¸Á, ±Þ¼º ½É±Ù°æ»öÁõ, ±ä±Þ °æÇÇÀû Àç°ü·ù¼ú, ±ä±Þ
¿Ü°úÀû ¿ìȸ¼ú(coronary artery bypass graft: CABG)
µî ÇÕº´Áõ ¾øÀÌ ÀÜ¿© ÇùÂøÀÌ 30% ¹Ì¸¸À̸ç, Thrombolysis
In Myocardial Infarction (TIMI) Ç÷·ùµî±Þ III
ÀÌ»óÀÎ °æ¿ì·Î Á¤ÀÇÇÏ¿´´Ù. º´º¯Ç÷°üÀÇ ¼ö¿Í °ü»óµ¿¸Æ
¿ÏÀüÆó¼â À¯¹«, TIMI flow µîÀ» ÃøÁ¤ÇÏ¿´À¸¸ç, PCI À¯¹«
¸¦ ±â·ÏÇÏ¿´´Ù. °ü»óµ¿¸Æ º´º¯ÀÇ ÇüÅÂÇÐÀû ºÐ·ù´Â ACC
/AHA (American College of Cardiology/American Heart
Association)¿¡¼­ Á¦½ÃÇÑ ACC/AHA classificationÀ» Âü
°íÇÏ¿´´Ù6).
3. Åë°è ºÐ¼®
ÀÚ·á´Â Æò±Õ¡¾Ç¥ÁØÆíÂ÷·Î Ç¥½ÃÇÏ¿´°í, SPSS for
windows (Version 12.0) Åë°è ¼ÒÇÁÆ®¿þ¾î¸¦ »ç¿ëÇÏ¿´À¸
¸ç, ¸í¸ñÀÚ·á ¹× ¿¬¼ÓÀÚ·á´Â °¢°¢ Chi-square¿Í 2-tailed
independent sample t-test·Î ºñ±³ ºÐ¼®ÇÏ¿´´Ù. ¸ðµç ÀÚ
·á´Â p °ªÀÌ 0.05 ¹Ì¸¸ÀÎ °æ¿ì¸¦ À¯ÀǼºÀÌ ÀÖ´Â °ÍÀ¸·Î
ÆÇÁ¤ÇÏ¿´´Ù.
°á °ú
1. ´ë»ó ȯÀÚÀÇ ÀÓ»óÀû Ư¡
Æò±Õ ¿¬·ÉÀº ¾ç ±º °£¿¡ Â÷ÀÌ´Â ¾ø¾úÀ¸¸ç, Çù½ÉÁõÀ̳ª
±Þ¼º ½É±Ù°æ»öÁõÀÇ °ú°Å·Âµµ ¾ç ±º °£ÀÇ Â÷ÀÌ´Â º¸ÀÌÁö
¾Ê¾Ò´Ù. °íÇ÷¾ÐÀÌ I±º¿¡¼­ ´õ ³ôÀº À¯º´À²À» º¸¿´À¸³ª,
Åë°èÀûÀÎ Àǹ̴ ¾ø¾ú´Ù. ÇÏÁö¸¸ I±º¿¡¼­ ´ç´¢º´(Group
I: 43.9%, Group II: 25.0%, p=0.035)°ú °íÁöÇ÷Áõ(I±º:
47.4%, II±º: 27.6%, p=0.028)ÀÌ À¯ÀÇÇÏ°Ô ³ô¾Ò´Ù. ±âŸ
BMI³ª ABI/PWV, ÁÂ½É½Ç ±¸Ç÷À² µîÀº ¾ç ±º °£¿¡ Â÷ÀÌ
´Â ¾ø¾ú´Ù(Ç¥ 1). ¾ç ±º °£¿¡ ¿°Áõ Ç¥ÁöÀÚ³ª ½É±ÙÈ¿¼Ò ¼ö
Ä¡, Ç÷Áß ÁöÁú ¼öÄ¡ µî¿¡¼­µµ À¯ÀÇÇÑ Â÷ÀÌ´Â º¸ÀÌÁö ¾Ê
¾Ò´Ù(Ç¥ 2). I±º¿¡¼­ °íÁöÇ÷ÁõÀÌ À¯ÀÇÇÏ°Ô ³ô¾ÒÀ½¿¡µµ Ç÷
Áß ÁöÁú ¼öÄ¡¿¡¼­ ¾ç ±º »çÀÌ¿¡ Â÷ÀÌ´Â ¾ø¾ú´ø °ÍÀº I±º
¿¡¼­ ÀÌ¹Ì ÁöÁú°­ÇÏÁ¦ µîÀÇ Ä¡·á¸¦ ÇÏ¿´±â ¶§¹®ÀÌ´Ù.
   
  0
3500
À­±Û ½Ç½Ã°£ ´º½º
¾Æ·¡±Û ¾çÆò±º Á¦Áõ¸í¼ö¼ö·á °í¿±Á¦È¯ÀÚ ±¹°¡À¯°øÀÚ¸éÁ¦
    N     ºÐ·ù     Á¦¸ñ    ±Û¾´ÀÌ ÀÛ¼ºÀÏ Á¶È¸
7718 ´äº¯ Re..°í¿±Á¦ÀÇÁõÀÇ ºñÂüÇÑ »ýÈ° KBSº¸µµ [4] ³ª±×³× 2008-06-09 2619
7717 Á¾±â,ºÎ½º·³ ¸í¾à ¼Ò·çÀåÀÌ ±èÈ«½Ä 2008-01-24 2619
7716 ³ª°¡¶ó ²Ãº¼°ßÀÔ´Ï´Ù ¹¹°¡ ÁÁ¾Ò¼­ °í¿±Á¦ ¸íÂû±îÁö ´Þ°í´ÜÀϱî? [1]+1 Áßµµ 2007-11-09 2616
7715 »ç¶÷ÀÌ ¿Ö °©Àڱ⠺¯ÇÒ±î¿ä!? °í¿±Á¦È¸¿¡¼­...... [3]+4 ÃʽÉ2 2007-10-17 2616
7714 ÀÇ°ß ÀμöÀ§¿øȸ¿¡¿ÃÀÎ °í¿±Á¦Àǵî¿ä±¸»çÇ× ÀμöÀ§¿ø¿¡¼­¿­¶ô [9]+10 ÃÖ»ó¿µ 2013-02-15 2613
7713 Re..°íÁ¤¹«Èñ ȸÀå´Ô»ï°¡¸íº¹À» º÷´Ï´Ù, ÃÖ»ó¿µ 2007-11-22 2606
7712 Re..4Â÷¿ªÇÐÁ¶»ç¿¡ Ãß°¡Áúº´Àº °íÇ÷¾Ð¹Û¿¡ ¾ø´Ù. ÃÖ»ó¿µ 2013-05-12 2605
7711 º¸ÈÆó °Ô½ÃÆÇ¿¡¼­ Æß (À̽ÃÁ¾ÀÇ¿ø½Ç¿¡ ¿Ã¶ó¿Â±ÛÀÔ´Ï´Ù, [2] ÃÖ»ó¿µ 2007-10-22 2604
7710 ½Ç¾î "³» ±Í¿¡ ¸Å¹Ì°¡ »ì¾Æ¿ä" "ÏÚ ±Í¿ï¸² ÇÇÇØÀÚÀÇ È£¼Ò" rnldnffla 2011-05-07 2603
7709 ´ë±¸µ¿±¸ ºÏÃÌ¿¡ 6.25¹×¿ù³²ÂüÀü À¯°øÀÚ ±â³äºñ Á¦¸· ÃÖ»ó¿µ 2008-06-23 2603
7708 Ä£ºÏ ¼¼·Âµé ±èö¼ö 2008-05-11 2603
7707 ¹Ý´ë °í¿±Á¦ Ãß°¡Áúº´ (Á¦6Â÷ ¹ý·ü¾È½É»ç¼ÒÀ§¿øȸ11¿ù22ÀÏ10 ½Ã [4]+2 ÃÖ»ó¿µ 2011-11-18 2602
7706 ½Ç¾î ¹Ýµð´Ô Ȥ½Ã Âü°í°¡ µÉ±îÇؼ­ Æۿ±ÛÀÔ´Ï´Ù [4]+4 ôìߣ(û»ê) 2012-02-02 2601
7705 ±è¹«¼ºÀÇ¿ø ¹ý¾ÈÇؼ® Á¤¹«À§¿ø±¹È¸ÀÇ¿ø¿¡°Ôº¸³»½Ã¿ä? ÃÖ»ó¿µ 2008-11-21 2601
7704 Ưº° Á¤¹«À§¿øȸ21ÀÏ È¸ÀÇÀÚ·áÀÔ´Ï´Ù,(´Ù½Ã¿Ã¸®ÀÔ´Ï´Ù) [1] ÃÖ»ó¿µ 2007-11-21 2601
7703 ¹Ý´ë ÇãÇ÷¼º½ÉÀåÁúȯ¿Ü °í¿±Á¦ ÀÔ¹ý¿¹°í °ø°í¹® ¹× °³Á¤¹ú·ü¾È Çѱ¹º£ÀÎÀü 2011-03-24 2600
1,,,11121314151617181920,,,500